Ousia Pharma

Ousia Pharma is a dynamic biotechnology research company dedicated to developing innovative peptide-small molecule drugs for the treatment of obesity and metabolic diseases. Utilizing a proprietary targeting approach, Ousia Pharma is at the forefront of creating peptide-drug conjugates that modulate synaptic plasticity, aiming for potent and sustained weight loss without compromising patient safety.

Located in Copenhagen, Ousia Pharma is focused on advancing its lead weight loss drug candidate (OP-56) for general obesity. The company’s commitment to cutting-edge research and development positions Ousia Pharma as a key player in the biotechnology sector, striving to make significant contributions to the health and well-being of individuals worldwide.

With its headquarters in Copenhagen, Ousia Pharma is poised for continued growth and success in the pharmaceutical landscape. We invite the manager of Ousia Pharma to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform, further highlighting your contributions to biotechnology research.